CanAlaska Uranium (CVE:CVV) Upgraded at Desjardins

CanAlaska Uranium (CVE:CVVGet Free Report) was upgraded by investment analysts at Desjardins to a “moderate buy” rating in a research note issued to investors on Thursday,Zacks.com reports.

Separately, Cormark raised CanAlaska Uranium to a “moderate buy” rating in a report on Tuesday, January 7th.

Get Our Latest Stock Report on CanAlaska Uranium

CanAlaska Uranium Stock Performance

Shares of CVV opened at C$0.73 on Thursday. CanAlaska Uranium has a 1-year low of C$0.53 and a 1-year high of C$1.00. The stock has a market cap of C$130.04 million and a PE ratio of -15.06. The stock’s 50 day simple moving average is C$0.80.

Insider Buying and Selling at CanAlaska Uranium

In other CanAlaska Uranium news, Director Geoffrey Gay acquired 75,000 shares of the stock in a transaction dated Monday, January 13th. The stock was acquired at an average price of C$0.75 per share, with a total value of C$56,250.00. Also, Senior Officer Peter George Dasler sold 50,000 shares of the stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of C$0.85, for a total value of C$42,500.00. In the last ninety days, insiders have sold 62,500 shares of company stock worth $51,675.

Featured Stories

Receive News & Ratings for CanAlaska Uranium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanAlaska Uranium and related companies with MarketBeat.com's FREE daily email newsletter.